These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 354780)

  • 1. Dietary lipid-dependent activation of the carcinogen N-2-fluorenylacetamide in rats as monitored by Salmonella typhimurium.
    Castro CE; Felkner IC; Yang SP
    Cancer Res; 1978 Sep; 38(9):2836-41. PubMed ID: 354780
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis.
    Stout DL; Becker FF
    Cancer Res; 1978 Aug; 38(8):2274-8. PubMed ID: 208764
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats.
    Schut HA; Thorgeirsson SS
    Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509
    [No Abstract]   [Full Text] [Related]  

  • 4. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
    Hinson JA; Andrews LS; Gillette JR
    Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship of 2-acetamidofluorene mutagenicity in plate tests with its in vivo liver cell component distribution and its carcinogenic potential.
    McGregor D
    Mutat Res; 1975 Dec; 30(3):305-15. PubMed ID: 1105163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation of 2-aminofluorene, 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene to bacterial mutagens with mussel (Mytilus galloprovincialis) and carp (Cyprinus carpio) subcellular preparations.
    Kurelec B; Krca S
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 88(1):171-7. PubMed ID: 2890481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N'-hydroxy-2-aminofluorene: the principal mutagen produced from N-hydroxy-2-acetylaminofluorene by a mammalian supernatant enzyme preparation.
    Stout DL; Baptist JN; Matney TS; Shaw CR
    Cancer Lett; 1976 May; 1(5):269-74. PubMed ID: 797443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium.
    Weeks CE; Allaben WT; Louie SC; Lazear EJ; King CM
    Cancer Res; 1978 Mar; 38(3):613-8. PubMed ID: 203386
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism and mutagenic activation of 2-acetylaminofluorene by human liver and lung.
    Boobis AR; Brodie MJ; McManus ME; Staiano N; Thorgeirsson SS; Davies DS
    Adv Exp Med Biol; 1981; 136 Pt B():1193-201. PubMed ID: 7046385
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives.
    Jacobs MM; Matney TS; Griffin AC
    Cancer Lett; 1977 May; 2(6):319-22. PubMed ID: 324608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 2-fluorenamine-induced mutagenesis in Salmonella typhimurium by vitamin A.
    Baird MB; Birnbaum LS
    J Natl Cancer Inst; 1979 Oct; 63(4):1093-6. PubMed ID: 384006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the structural isomer N-3-fluorenylacetamide on microsomal binding and hydroxylation of the carcinogen N-2-fluorenylacetamide.
    Chow YM; Gutmann HR; Kaplan E
    Biochem Pharmacol; 1981 Jun; 30(11):1253-61. PubMed ID: 7271824
    [No Abstract]   [Full Text] [Related]  

  • 13. Activation of 2-acetylaminofluorene in the nuclei of rat liver.
    Kawajiri K; Yonekawa H; Hara E; Tagashira Y
    Cancer Res; 1979 Mar; 39(3):1089-93. PubMed ID: 427750
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
    Razzouk C; Batardy-Grégoire M; Roberfroid M
    Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene.
    Beranek DT; White GL; Heflich RH; Beland FA
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5175-8. PubMed ID: 6752940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of in vitro mutagenic activation and covalent binding of N-hydroxy-2-acetylaminofluorene in isolated liver cell nuclei from rat and mouse.
    Sakai S; Reinhold CE; Wirth PJ; Thorgeirsson SS
    Cancer Res; 1978 Jul; 38(7):2058-67. PubMed ID: 26463
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538.
    Weeks CE; Allaben WT; Tresp NM; Louie SC; Lazear EJ; King CM
    Cancer Res; 1980 Apr; 40(4):1204-11. PubMed ID: 6986982
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of the Ames test in assessing the relation of dietary lipid and antioxidants to N-2-fluorenylacetamide activation.
    Black HS; Gerguis J
    J Environ Pathol Toxicol; 1980 Aug; 4(1):131-8. PubMed ID: 7441107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subnanogram estimation of the proximate carcinogen N-hydryxy-2-fluorenylacetamide by gas-liquid chromatography.
    Razzouk C; Lhoest G; Roberfroid M; Mercier M
    Anal Biochem; 1977 Nov; 83(1):194-203. PubMed ID: 920936
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic activation of 2-acetylaminofluorene.
    Thorgeirsson SS; Wirth PJ; Staiano N; Smith CL
    Adv Exp Med Biol; 1981; 136 Pt B():897-919. PubMed ID: 7046390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.